Randomised, Controlled, Cross-Over Trial of Soy Protein with Isoflavones on Blood Pressure and Arterial Function in Hypertensive Subjects
Helena J. Teede, MBBS, PhD,
Dimitra Giannopoulos, BSci,
Fabien S. Dalais, PhD,
Jonathan Hodgson, PhD and
Barry P. McGrath, MBBS, MD
Vascular Sciences Research Group, Monash University Department of Medicine, Dandenong Hospital, Melbourne (H.J.T., D.G., F.S.D., B.P.M.)
Jean Hailes Research Group, Monash Institute Health Services Research, Clayton (H.J.T.)
Victoria, University of Western Australia, School of Medicine and Pharmacology, Perth, Western Australia (J.H.), AUSTRALIA

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1. Ambulatory blood pressure total systolic, total diastolic, awake systolic and awake diastolic blood pressures. There was no difference between baseline and 3 months of intervention in the active or placebo groups.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2. Mean Systemic Arterial Compliance (SAC) (±SEM), Endothelial function [Flow mediated vasodilation (FMD)], Pulse wave velocity [PWVA-F (central) and PWVF-D (peripheral)] during the soy versus gluten placebo groups in males and females. There was no difference between baseline and 3 months of intervention in the active or placebo groups.
|
|
Copyright © 2006 by the American College of Nutrition.